Dear readers of ADxS.org, please forgive the disruption.

ADxS.org needs about $19740 in 2023. In 2022 we received donations from third parties of about $ 13870. Unfortunately, 99.8% of our readers do not donate. If everyone who reads this request makes a small contribution, our fundraising campaign for 2023 would be over after a few days. This donation request is displayed 12,000 times a week, but only 140 people donate. If you find ADxS.org useful, please take a minute and support ADxS.org with your donation. Thank you!

Since 01.06.2021 ADxS.org is supported by the non-profit ADxS e.V..

$0 of $19740 - as of 2023-01-03
0%
Header Image
Mirtazapine for ADHD

Sitemap

Mirtazapine for ADHD

Brand name: Remergil

Dopaminergic, adrenergic, and noradrenergic but not serotonergic antidepressant.

Increases dopamine release in the PFC and noradrenergic transmission in cortical-limbic areas.1

The serotonin level is only marginally affected.1

After 21 days of mirtazapine treatment, rats showed desensitization of presynaptic a2 heteroreceptors at the 5-HT nerve terminal in the hippocampus. This caused increased tonic activation of postsynaptic 5-HT1A receptors.2 This increased tonic activation of inhibitory 5-HT1A receptors could explain the increased CRH release in the HPA axis, which was acutely reduced before treatment initiation.3

Diese Seite wurde am 08.08.2022 zuletzt aktualisiert.